PC
HALO icon

Passport Capital’s Halozyme HALO Stock Holding History

Passport Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,573
Closed -$178K – 196
2014
Q3 		$178K Sell
19,573
-4,950
-20% -$47.1K ﹤0.01% 200
2014
Q2 		$242K Buy
24,523
+8,750
+55% +$74.2K ﹤0.01% 144
2014
Q1 		$200K Buy
+15,773
New +$234K 0.01% 159

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Passport Capital's HALO Position: Q4 2014 in Review

Passport Capital sold out of Halozyme (HALO) in Q4 2014, closing a stake of 19,573 shares — an estimated $178K sold.

Passport Capital first reported a position in HALO in Q1 2014 and held it in 3 quarters. The position peaked at $242K in Q2 2014. 132 funds tracked by Wall St. Rank hold HALO as of Q4 2014.

  • Passport Capital reported no remaining Halozyme position as of Q4 2014 after selling out during the quarter.
  • Passport Capital sold 19,573 Halozyme shares in Q4 2014, an estimated $178K.
  • Passport Capital first reported a position in Halozyme in Q1 2014 and held it in 3 quarters.
  • Passport Capital's Halozyme position peaked at $242K in Q2 2014.
  • 132 funds tracked by Wall St. Rank held Halozyme as of Q4 2014.

Based on Passport Capital's 13F filing for Q4 2014, filed 17 Feb 2015.